Stoke Therapeutics Inc (NASDAQ:STOK)

17.70
BATS BZX Real-Time Price
As of 12:47pm ET
 -0.17 / -0.95%
Today’s Change
17.09
Today|||52-Week Range
68.00
-26.22%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 65.00, with a high estimate of 83.00 and a low estimate of 41.00. The median estimate represents a +267.23% increase from the last price of 17.70.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.62
Sales
$0.00
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.45%
 
 
 
 
 
 
Growthannually -47.50%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.